Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The "cytokine profile": a code for sepsis.

Luis Ulloa1, Kevin J Tracey

  • 1Center of Immunology and Inflammation, North Shore-LIJ Research Institute, 350 Community Drive, Manhasset, NY 11030, USA. Lulloa@nshs.edu

Trends in Molecular Medicine
|February 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative analysis of HMGB1 and pCTS-L immunomodulatory properties in human peripheral blood mononuclear cells.

Frontiers in immunology·2026
Same author

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis.

Military Medical Research·2026
Same author

Central neurons encode interleukin-1β signals and mediate stress-induced inflammation.

The Journal of experimental medicine·2026
Same author

Non-invasive identification of brain signatures of acute liver injury.

Theranostics·2026
Same author

Myofibroblasts Induce Neuroplasticity to Promote Pancreatic Inflammation and Cancer Progression.

Cancer discovery·2026
Same author

Nociceptor α7nAChR activation blunts neuronal HMGB1 release and attenuates inflammation and nociceptive behavior.

Molecular medicine (Cambridge, Mass.)·2025

Sepsis, a leading cause of death, affects millions globally. Current treatments are modestly effective, suggesting the broad sepsis definition needs refinement for targeted therapies based on cytokine expression profiles.

Area of Science:

  • Critical care medicine
  • Immunology
  • Pathophysiology

Background:

  • Sepsis is a major cause of mortality in hospitalized patients, with incidence increasing annually.
  • Existing therapeutic strategies show limited efficacy in clinical trials, despite effectiveness in similar conditions.
  • The underlying reasons for treatment failure in sepsis remain debated.

Purpose of the Study:

  • To address the limited efficacy of current sepsis treatments.
  • To propose a re-evaluation of the broad clinical definition of sepsis.
  • To suggest future research directions for more personalized sepsis management.

Main Methods:

  • Review of recent clinical trial data and experimental strategies.
  • Analysis of the heterogeneity within the current sepsis diagnosis.

Related Experiment Videos

  • Exploration of cytokine expression profiles for patient stratification.

    • Main Results:

    • Current therapeutic approaches for sepsis have shown only modest effects.
    • The broad definition of sepsis may encompass distinct patient subgroups with different underlying syndromes.
    • Cytokine expression profiling offers a potential method for differentiating these subgroups.

    Conclusions:

    • The current, generalized definition of sepsis is likely too broad.
    • Future clinical trials should stratify patients based on specific biomarkers, such as cytokine expression.
    • Personalized therapeutic strategies tailored to patient subgroups may improve sepsis outcomes.